Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436618
Status:
COMPLETED
Last Update Posted:
2019-10-22
First Post:
2007-02-15
Brief Title:
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoproliferative Disorder |
| Leukemia |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent adult Hodgkin lymphoma | View |
| anaplastic large cell lymphoma | View |
| angioimmunoblastic T-cell lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |
| splenic marginal zone lymphoma | View |
| small intestine lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult T-cell leukemialymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent marginal zone lymphoma | View |
| refractory chronic lymphocytic leukemia | View |
| recurrent small lymphocytic lymphoma | View |
| recurrent mycosis fungoidesSezary syndrome | View |
| adult nasal type extranodal NKT-cell lymphoma | View |
| Waldenstrom macroglobulinemia | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| primary central nervous system non-Hodgkin lymphoma | View |
| primary central nervous system Hodgkin lymphoma | View |
| post-transplant lymphoproliferative disorder | View |